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Purpose: This study tested the logistical feasibility of obtaining data on social support systems 
from cancer patients enrolled on clinical trials and compared the social support of older adults 
(age 65) and younger adults (50 years of age) with cancer.
Methods: Patients had to be eligible for a phase II or phase III oncology clinical trial and 
enter the study prior to treatment. Patients filled out the Lubben Social Network Scale (LSNS) 
at baseline. The Symptom Distress Scale (SDS) and single-item overall quality of life (QOL) 
Uniscale were assessed at baseline and weekly for 4 weeks.
Results: There was no significant difference in overall mean Lubben social support levels 
by age. Older patients had more relatives they felt close to (85% versus 53% with 5 or more 
relatives, P = 0.02), heard from more friends monthly (84% versus 53% with 3 or more friends, 
P = 0.02), less overall symptom distress (P = 0.03), less insomnia (P = 0.003), better concentration 
(P = 0.005), better outlook (P = 0.01), and less depression (P = 0.005) than younger patients.
Conclusions: Younger subjects reported worse symptoms, a smaller social support network, 
and fewer close friends and relatives than older subjects. Having someone to discuss decisions 
and seeing friends or relatives often was associated with longer survival.
Keywords: social support, Lubben scale, QOL, elderly
Approximately 10.1 million individuals in this country have a history of cancer and 
1,372,910 new individuals were diagnosed in the year 2006. The prevalence of cancer 
is about 13% in patients 18–49 and about 60% in ages 65 or over.1 Receiving a cancer 
diagnosis affects individuals in a multitude of ways. It is critical for cancer patients to 
have support, especially in light of the fear and social ‘stigma’ of cancer.2 The avail-
ability of support may decrease as a result of these issues and social networks of older 
people tend to be smaller than those of younger individuals.3,4 In previous studies in 
noncancer cohorts, better social support has been linked to longer survival times,5,6 
lower hospitalization rates,7 better adjustment after diagnosis of disease,8 and better 
retention of cognitive function.9 More research is needed on the impact of social net-
works among cancer patients.
Studies have reported the positive effects of social support at the time of diagnosis 
and during adaptation to the disease.10–16 Conversely, cancer patients with diminished 
emotional support report more symptoms and lower QOL.14,17 Cancer patients have 
unique social support issues. For them, support from a spouse, immediate family, 
and peers are critical.15,18 The fear associated with cancer diagnosis and treatment 
increase the need for support,14,19 while at the same time the social stigma of having 
cancer can decrease the availability of support when it is most needed.14,20,21 Social Cancer Management and Research 2010:2 134
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support models must be tailored to fit the specific needs of 
the individual because social support needs vary by treatment 
and stage of disease.11,14,16,22
The primary goal of this pilot study was to gain 
experience with assessing social support in cancer patients. 
This experience will lead to further studies of social networks 
in this cohort. The research hypotheses for this study were 
that the level of social support diminishes with age and 
has an impact on secondary goals. These secondary goals 
included symptoms captured by the SDS, mortality, and 
overall QOL.
Methods
study design
The present study was a prospective, non-randomized cohort 
design. The accrual goal was 30 patients in each group. This 
sample size would provide 80% power to detect a difference 
of 0.7 of a standard deviation between the two groups. This 
effect size is considered a moderate to large effect size.23 
Completion rates were calculated, with 80% completeness 
as a criterion for acceptability for further study.
Patients
This study was approved by the Mayo Foundation Institutional 
Review Board and participants provided informed consent. 
Patients had to be eligible for a Mayo phase II or III oncology 
clinical trial and had to be enrolled on this study prior to 
starting treatment for their primary malignant disease. Two 
groups of patients were entered on this study. Patients at 
least 18 years old and less than 50 years old were entered 
into a group considered young cancer patients, and patients 
at least 65 years old were entered into a group considered 
older adults. These two age groupings were selected to 
maximize the potential to demonstrate the effects of age on 
social support. Patients were enrolled between 7/16/1999 and 
01/11/2002. Accruing younger patients proved more difficult 
than expected, given the lower incidence rate of cancer in 
younger adults. Nationally, only about 13% of cancer patients 
are under the age of 50.24 At our institution, about twice as 
many patients age 65 or older go on phase II or III studies 
compared to patients less than age 50. Accrual for this younger 
cohort was stopped at 20 because of the slow accrual rate.
Measures
Lubben social network scale
The Lubben Social Network Scale (LSNS) is a validated 
self-reported 10 item scale measuring embedded support, 
perceived support, and the reciprocation of support.25–28 All 10 
items are highly intercorrelated (Cronbach’s alpha = 0.70).29,30 
Each question was scored on a zero to five scale with high 
scores indicating more social support. The overall LSNS 
social support score was calculated for each patient by sum-
ming the 10 questions. The LSNS was assessed at baseline 
before the patient started their cancer treatment. Our group 
recently used this same scale in a retrospective analysis of 
two lung cancer clinical trials to successfully demonstrate 
a lack of gender effect in social support among elderly 
patients.31 Differences in the individual LSNS questions 
were also analyzed.
The uniscale overall quality of life scale
The Uniscale32 tool used in this study was a single item visual 
analogue. Patients mark an ‘X’ along a bar to indicate their 
overall QOL. The bar ranges from ‘LOWEST QUALITY’ on 
the left side of the bar to ‘HIGHEST QUALITY’ on the right 
side of the bar. The patient’s score is the measured distance 
from the left of the bar to the ‘X’ divided by the total length 
of the bar times 100. Scores then range from 0 to 100 with 
100 being the best possible score. The UNISCALE has been 
validated in cancer clinical trials.33 The Uniscale was assessed 
at baseline (before the start of treatment) and weekly for the 
remaining four weeks of the study.
The symptom distress scale
The Symptom Distress Scale (SDS)34 is a reliable and 
validated, self-reported 13-item questionnaire designed to 
identify physical and psychosocial symptoms of concern 
to patients and the degree of distress associated with each 
symptom. The scale has demonstrated convergent validity 
with the MOS-SF36 and discriminant validity has been 
established.35 The SDS was assessed at baseline (before 
the start of treatment) and weekly for the remaining four 
weeks of the study. For this and for all other patient-reported 
outcomes we translate scores onto a 0–100 point scale, where 
appropriate, so that higher scores always mean a positive 
indication for the patient (less pain or symptom distress, 
better quality of life).
Analysis plan
This prospective study compared social support, symptoms 
and QOL between the cohort of younger patients and the 
cohort of older patients. Secondary analyses included 
testing for gender differences. Fisher’s exact tests were 
used to test for differences in discrete variables between 
groups. Kruskal-Wallis tests were used to test differences 
in continuous variables between the two age groups, Cancer Management and Research 2010:2 135
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Kaplan-Meier curves and log-rank tests were used to compare 
survival between the groups, and Spearman correlations were 
used to determine associations between social support and 
symptoms. Changes in symptoms and QOL over time were 
tested by applying t-tests to the differences between baseline 
and week 4 values.
Results
Demographics
Table 1 shows baseline demographics between the older and 
younger cohort. The baseline demographics were similar 
between the two groups. Almost all (93%) of the patients 
had late stage cancer.
LsNs form completion
During this 3-year period, 52 patients were enrolled in this 
study. Two patients did not provide any baseline information. 
Out of the 50 patients with baseline information, 41 (82%) 
filled out the LSNS. This completion percentage was suf-
ficient to recommend the use of the LSNS in future studies 
of this patient population.
Age differences in social support networks
Table 2 and Figure 1 show LSNS by age group. There was 
no significant difference in overall mean LSNS by age (76.4 
for younger patients, 80 for older patients, P = 0.49). How-
ever, contrary to the pre-study hypothesis, younger patients 
had lower levels of social support than older patients on 
individual Lubben questions. Patients in the younger group 
were more likely relied on by others on a daily basis (69% 
vs 35%, P = 0.04). Despite having advanced cancer, the 
younger patients had the added stress of being responsible 
for others. Patients 65 years of age had more relatives they 
felt close to (85% vs 54% with 4 relatives, P = 0.017) and 
Table 1 Baseline characteristics by age group
  Age 50 (N = 20) Age ≥65 (N = 32) Total (N = 52) P value
Age
  Mean (sD) 42.3 (6.08) 71.2 (3.45) 60.1 (14.93) NA
  Median 44.0 71.0 69.0
  Range 29 to 49 65 to 80 29 to 80
Age group
  26 to 30 1 (5%) – 1 (2%)
  31 to 35 3 (15%) – 3 (6%)
  36 to 40 3 (15%) – 3 (6%)
  41 to 45 6 (30%) – 6 (12%)
  46 to 50 7 (35%) – 7 (13%)
  65 to 70 – 16 (50%) 16 (31%)
  71 to 75 – 12 (38%) 12 (23%)
  76 to 80 – 4 (12%) 4 (8%)
site 0.13
  gi 7 (35%) 13 (41%) 20 (38%)
  gU 6 (30%) 4 (13%) 10 (19%)
  Lung 1 (5%) 8 (25%) 9 (17%)
  Breast 0 (0%) 2 (6%) 2 (4%)
  Other 6 (30%) 5 (16%) 11 (21%)
stage 0.77
  Missing 5 1 6
  early (stage i, ii) 1 (5%) 2 (7%) 3 (7%)
  Late (stage iii, iV) 18 (95%) 25 (93%) 43 (93%)
gender 0.76
  Female 9 (45%) 13 (41%) 22 (42%)
  Male 11 (55%) 19 (59%) 30 (58%)
Baseline QOL 0.36
  Mean (sD) 74.4 (16.5) 77.0 (20.2) 76.0 (18.8)  Cancer Management and Research 2010:2 136
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Table 2 Lubben social Network scale levels by age group
  Age 50 (N = 20) Age 65 (N = 32) Total (N = 52) P value
Lubben social Network score (0–100) 0.49
  Mean 76.4 80.0 78.7
  sD 12.45 11.40 11.77
how many relatives do you see or hear from at least  
once a month? (NOTe: include in-laws with relatives)
0.20
  0 0% 4% 3%
  1 0% 0% 0%
  2 13% 0% 5%
  3–4 13% 12% 13%
  5–8 27% 16% 20%
  9 or more 47% 68% 60%
Tell me about the relative with whom you have the most  
contact. how often do you see or hear from that person?
0.67
  Less than monthly 0% 4% 2%
  Monthly 0% 0% 0%
  A few times a month 7% 0% 2%
  Weekly 13% 12% 12%
  A few times a week 40% 38% 39%
  Daily 40% 46% 44%
how many relatives do you feel close to? That is, how  
many of them do you feel at ease with, can talk to about  
private matters, or can call on for help?
0.02
  0 0% 0% 0%
  1 0% 0% 0%
  2 13% 0% 5%
  3–4 33% 15% 22%
  5–8 33% 35% 34%
  9 or more 20% 50% 39%
Do you have any close friends? That is, do you have friends  
with whom you feel at ease, can talk to about private  
matters, or can call on for help? if so, how many?
0.09
  0 0% 4% 2%
  1 0% 4% 2%
  2 6% 8% 20%
  3–4 33% 38% 37%
  5–8 20% 19% 20%
  9 or more 7% 27% 20%
how many of these friends do you see or hear from  
at least once a month?
0.02
  0 7% 0% 2%
  1 7% 4% 5%
  2 33% 12% 20%
  3–4 33% 31% 32%
  5–8 13% 31% 24%
  9 or more 7% 23% 17%
Tell me about the friend with whom you have the most  
contact. how often do you see or hear from that person?
0.25
  Less than monthly 0% 0% 0%
  Monthly 14% 4% 8%
(Continued)Cancer Management and Research 2010:2 137
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Table 2 (Continued)
  Age 50 (N = 20) Age 65 (N = 32) Total (N = 52) P value
  A few times a month 7% 8% 8%
  Weekly 14% 54% 40%
  A few times a week 36% 23% 28%
  Daily 29% 12% 18%
When you have an important decision to make, do you  
have someone you can talk to about it?
0.25
  Never 0% 0%
  seldom 0% 0%
  sometimes 0% 0%
  Often 20% 12%
  Very often 7% 0%
  Always 73% 88%
When other people you know have an important 
decision to make, do they talk to you about it?
0.59
  Never 0% 4% 3%
  seldom 0% 0% 0%
  sometimes 20% 24% 23%
  Often 27% 36% 33%
  Very often 47% 16% 28%
  Always 7% 20% 15%
Does anybody rely on you to do something for them  
each day? For example: shopping, cooking dinner, doing  
repairs, cleaning house, providing child care, etc?
0.04
  No 31% 65% 54%
  Yes 69% 35% 46%
Do you help anybody with things like shopping, filling  
out forms, doing repairs, providing child care, etc?
0.63
  Never 0% 10% 8%
  seldom 17% 25% 23%
  sometimes 67% 40% 46%
  Often 0% 20% 15%
  Very often 0% 0% 0%
  Always 17% 5% 8%
Do you live alone or with other people? 0.87
  Live alone 13% 15% 15%
  Live with other unrelated individuals (eg, paid help) 0% 0% 0%
  Live with other relatives or friends 13% 8% 10%
  Live with spouse 73% 77% 76%  
more friends they heard from monthly (85% vs 54% with 
2 friends, P = 0.016).
Age differences in symptoms
Figure 2 shows that older patients reported fewer symptoms 
than the younger patients. Older patients reported less 
overall symptom distress (mean of 86 vs 77, P = 0.03), 
less insomnia (11% vs 47% with frequent trouble sleeping, 
P = 0.003), better concentration (81% vs 40% with their 
normal ability to concentrate, P = 0.005), better outlook 
(86% vs 40% with little or no worries, P = 0.01), and 
less depression (74% vs 27% seldom feel depressed, 
P = 0.005).
social support levels and symptoms by gender
There were no significant differences in overall social 
support levels by gender (mean overall LSNS scores of 
81 for females vs 77 males, P = 0.40). However, females Cancer Management and Research 2010:2 138
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were more likely to see close relatives daily (70% vs 19%, 
P = 0.0027) and were more likely to have other people 
discuss their problems with them (60% of women reported 
“very often” or “always” compared to only 25% of men, 
P = 0.02). Women reported more overall symptom distress 
at baseline (mean overall SDS score of 78 vs 86 for men, 
P = 0.02) and a higher frequency of SDS pain (10% of 
women almost never had pain vs 59% of men, P = 0.005).
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Age dfferences in QOL
There were no statistically significant differences in baseline 
quality of life or changes in quality of life by age group or 
gender.
Age differences in survival
There were no statistically significant differences in survival 
times by age group (log-rank P = 0.98). There was no a 
survival difference even after adjusting for stage of disease 
and gender (Cox model P = 0.60).
social support and survival
Due to the small sample size and the lack of a survival 
difference, the two age cohorts were combined to explore 
the relationship between social support and survival. Some 
levels of the LSNS questions were also combined because of 
the sparse responses in some levels. As shown in Figure 3, 
always having someone to talk to about decisions was a 
significant predictor for survival even after adjusting for 
age and gender (Cox proportional hazard P = 0.01, hazard 
ratio = 0.31, 95% confidence interval for the odds ratio of 
0.002 to 0.492). For this analysis, patients with responses 
of ‘often’ and ‘very often’ were combined and compared to 
patients responding with ‘always’.
Correlations between social support and symptoms
There was a modest correlation between symptoms and how 
often they saw their closest friend (−0.50 correlation with 
overall SDS, and 0.51 correlation with fatigue).
Changes in symptoms and QOL over time.
There were no significant differences in the changes in symp-
toms or QOL over time by age group. The combined cohort of 
patients in both age groups showed a significant decrease in 
QOL over time (mean decrease of 7.9, P = 0.02), a decrease 
in pain frequency (mean improvement of 0.4, P = 0.02), and 
a decrease in SDS outlook (mean decrease −0.3, P = 0.04).
Discussion
Social support networks are important factors in the health 
of the elderly.36,37 Better social support networks have been 
linked with patient survival, overall health, their ability to 
carry out routine daily tasks, and their ability to cope with 
major life events and disease.5,38–40 Patients can become 
very isolated after a cancer diagnosis due to the social 
stigma associated with cancer, but this is the time these 
patients need the most support, and their level of support 
is associated with outcome. Recent evidence has emerged 
that both supports the importance of social networks on 
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health41,42 and challenges the notion that older adults are 
more isolated.43
This study suggests there may be a generational gap in 
the level of social support experienced by cancer patients. 
In this study, younger patients tended to have smaller sup-
port networks and fewer close friends. Younger patients also 
reported higher levels of symptoms. These results were in 
perfect opposition to our research hypothesis. The reasons 
for these results should be explored further. It is possible 
that the younger patients do not have a spouse or partner to 
lean on or their parents or other family members around for 
support. Their friends are younger and may be busy with 
their own careers and families. The rapid growth of internet 
social networks may also have resulted in an increase in 
the size of social networks, but a decrease in face-to-face 
social skills and therefore less direct social networking 
among younger adults. The effects of internet networking 
on cancer patients, requires further investigation. It is also 
possible that older patients had developed social networks 
as they aged in response to previous illness and disability 
and that these established social networks were maintained. 
Younger patients would be less likely to have developed and 
maintained similar social networks. The younger patients 
also were more likely to be relied on by others on a daily 
basis. This likely meant the patients had the added burden 
of dealing with how their cancer will affect their young 
children or a spouse.
Age group and gender were not significant factors for 
survival in this study. These results are not terribly surprising 
in that the impact of age group44,45 and gender46,47 on survival 
is variable across patient populations and clinical studies. 
However, there was some evidence that having someone to 
discuss decisions with and being able to see friends and rela-
tives often was linked to longer survival. This is an intriguing 
result that requires further investigation.
This study suggests that cancer patients may benefit 
from a system that fosters positive, supportive social net-
works. Social networking with close trusted friends and 
relatives should be encouraged, as these interactions promote 
improved quality of life and longer survival. Cancer health 
providers should be aware of the potential for social isola-
tion and its effects on cancer patients.48 Future interventions 
could include screening for insufficient social networks, 
enhancing and encouraging existing social networks, and 
connecting isolated patients to potential social links. The 
quality of these social networks also needs to be considered. 
Social supports need to be positive, supportive and tailored 
to the individual.
A methodological note from this study indicates that the 
LSNS was easy for participants to complete and provided 
reasonably detailed data on the relative well-being of patient 
social networks. In particular, the use of individual item 
analysis provided supplementary insights that could not be 
garnered from the total score. This is a phenomenon that 
has been seen in other studies and is a particular focus of 
the research program of the senior author.49,50 These findings 
have supported the examination of results for individual 
items within a summated score since changes in individual 
items may be lost among the summated scores of multi-item 
assessments.
A limitation of this study is that the patients were all 
from cancer clinical trials. Patients going on clinical trials 
are only a small fraction of all cancer patients and they may 
have higher levels of support than other patients. Higher 
levels of support are likely needed for patients on clinical 
trials to support the extra trips and expenses. The findings 
may be magnified in patients not able to participate in a 
clinical trial.
Future research
The data suggest that social networks can be successfully 
evaluated in cancer patients. More definitive studies are 
needed into the differences in social support networks 
between age groups, the impact of social networks on 
patient outcomes, and the impact of identifying and 
alleviating social isolation. Future plans include testing 
an intervention targeted at improving social networks in 
patients identified as having low social support. A “menu” 
of support services will be assembled by the investigators 
and provided to patients to see if patients that receive 
structured, active encouragement and information from 
an enhanced social network will report higher QOL, 
fewer symptoms, and improved toxicity profiles. Future 
studies will also include patients in the middle age group 
(50 to 64).
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